32130 Tirzepatide for Sale
Compare supplier listings for Tirzepatide (CAS 2023788-19-2) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Tirzepatide good price 99% Purity Powder High Quality Fast Delivery
-
Price:
$20-25/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5 mg/vial 10 mg/vial 15 mg/vial 20 mg/vial 30 mg/vial 40MG/vial 60mg/vial
peptides
.,证书
High quality Tirzepatide 99% raw material powder Cas. 2023788-19-2
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5g/Drum
APIs,Veterinary,Cosmetic Ingredients,Peptides,intermediates,food ingredients
Tirzepatide 99% white powder
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Top Product
-
Content:
99%
-
Packaging:
mg
Pharmaceutical Peptide,Cosmetic peptide,Custom peptides,API polypeptide,Amino acids and derivatives
High Purity 99% Quality Peptides Lyophilized Powder Tirzepatide Fitness and Weight Loss
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
High Purity Grade
-
Content:
99%
-
Packaging:
10mg*10vials
Tirzepatide Weight Loss Peptides Purity 99% Weight Management Obesity Treatment Tirz(LY3437943) 10mg Tirzepatide Semaglutide Retatrutid
-
Price:
$1/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial 10vials/box
semaglutide,tirzepatide,retatrutide
Products You May Be Interested in
Tirzepatide Lyophilized for Weight loss and fitness training API Powder Bulk Wholesale Raw Material
-
Price:
$40-45/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg,10mg,20mg,30mg,40mg,50mg,60mg10vials/box
Tirzepatide Top quality peptide cosmetic peptide weight loss 99%purity
-
Price:
$40-50/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg 10mg 15mg/vial,10vials/box
transportation, safe arrival, 99% high quality weight loss products, we also have raw material products.
-
Price:
$40-50/MT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.9%
-
Packaging:
5mg/vial
Tirzepatide Lyophilized for Weight loss and fitness training API Powder Bulk Wholesale Raw Material,60mg
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg,10mg,20mg,30mg,60mg/vial,10vials/box
Retatrutide,Tirzepatide,Semaglutide
Tirzepatide Retatruide Semaglutide 99% pure peptide raw material flour factory
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
1g
GLP-1,Retatrutide,Tirzepatide,Peptides
- If you want to buy Tirzepatide, then ECHEMI will offer you multi-options. ECHEMI emphasizes on verifying suppliers of Tirzepatide who have registered on the platform to ensure the accuracy and reliability of suppliers. Accurate information is the prerequisite of transaction. Find your Tirzepatide order with 70000+ buyers on ECHEMI.
- The quality of Tirzepatide 2023788-19-2 will be secured by ECHEMI. Partners on ECHEMI are all selected in certification, qualification or scale. Tirzepatide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Member registered on ECHEMI will enjoy services of Tirzepatide for example market price and insights and trade data. ECHEMI provides the whole supply chain services to with efficient online options. We will help you purchase Tirzepatide and run fast your business.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide